These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10270310)

  • 1. Minimizing waste of prepared sterile products.
    Davis NM
    Hosp Pharm; 1985 Feb; 20(2):109-13, 117. PubMed ID: 10270310
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for phenytoin infusions.
    Tuttle CB
    Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensuring the safety and efficacy of extemporaneously prepared infusions.
    Driscoll DF
    Nutrition; 1996 Apr; 12(4):289-90. PubMed ID: 8862541
    [No Abstract]   [Full Text] [Related]  

  • 8. I.V. admixture profiling: a simple system.
    Grabowski B; Tanner DJ
    Hosp Pharm; 1979 May; 14(5):245-6, 248, 252-4 passim. PubMed ID: 10242202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Special problems in the development of modern infusion solutions].
    Frank P
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
    [No Abstract]   [Full Text] [Related]  

  • 13. Subvisible Particulate Contamination in Cell Therapy Products-Can We Distinguish?
    Vollrath I; Mathaes R; Sediq AS; Jere D; Jörg S; Huwyler J; Mahler HC
    J Pharm Sci; 2020 Jan; 109(1):216-219. PubMed ID: 31521641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 15. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique.
    Morris BG; Avis KE; Bowles GC
    Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint commission to survey compliance with new USP-NF Chapter on compounding sterile preparations.
    Jt Comm Perspect; 2004 Apr; 24(4):4-5. PubMed ID: 15085694
    [No Abstract]   [Full Text] [Related]  

  • 17. Parenteral Drug Association response to FDA proposal to prohibit the use of any antimicrobial preservative in single-dose parenteral drug products.
    J Parenter Sci Technol; 1985; 39(6):231-2. PubMed ID: 4093824
    [No Abstract]   [Full Text] [Related]  

  • 18. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parenteral administration medicines: recommendations of preparation, administration and stability].
    Gaspar Carreño M; Torrico Martín F; Novajarque Sala L; Batista Cruz M; Ribeiro Gonçalves P; Porta Oltra B; Sánchez Santos JC
    Farm Hosp; 2014 Nov; 38(6):461-7. PubMed ID: 25542656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
    Blackstone M; Hauser LD
    Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.